46 results on '"Cardin, R."'
Search Results
2. OC.07.6 THE ROLE OF HELICOBACTER PYLORI IN AUTOIMMUNE ATROPHIC GASTRITIS: DISEASE PHENOTYPE AND MIRNA EXPRESSION
3. OC.07.3 AUTOIMMUNE ATROPHIC GASTRITIS: DIFFERENCES BETWEEN HELICOBACTER PYLORI ASSOCIATED AND NON-ASSOCIATED DISEASE
4. AF.56 COMPARATIVE ASSESSMENT OF INFLIXIMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
5. AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
6. OC.05.1 IDENTIFICATION OF MARKERS OF OXIDATIVE STRESS IN CELIAC DISEASE
7. OC.04.6 CIRCULATING PROSTAGLANDIN E2: A NOVEL POTENTIAL PROGNOSTIC BIOMARKER IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
8. Circulating prostaglandin E2: A novel potential prognostic biomarker in patients with hepatocellular carcinoma
9. OC.05.1 MICRORNA-21 AND MICRORNA-122: PROGNOSIS PREDICTION AND CORRELATION WITH HIF-1ALPHA IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH TRANSARTERIAL CHEMOEMBOLIZATION
10. OC.05.3 ENDOTHELIAL DAMAGE IN THE PORTAL VEIN OF PATIENTS WITH CIRRHOSIS
11. OC.05.6 GENDER-RELATED DIFFERENCES IN SCCA-IGM LEVELS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH TRANSARTERIAL CHEMOEMBOLIZATION
12. Circulating microRNA-21 and microRNA-122: prognosis prediction and correlation with HIF-1alpha in hepatocellular carcinoma patients treated with transarterial chemoembolization
13. SCCA-IgM in hepatocellular carcinoma patients treated with transarterial chemoembolization: gender-related differences
14. P.07.28 PREVIOUS EXPOSURE TO INFLIXIMAB INDUCES CROSS-REACTIVITY AND AFFECTS ADALIMUMAB TROUGH LEVELS: DATA FROM A PROSPECTIVE, MULTICENTRE STUDY
15. OC.12.4 RAPID POINT-OF-CARE MONITORING OF ANTI-INFLIXIMAB ANTIBODIES AND CLINICAL SCORES IN INFLAMMATORY BOWEL DISEASE PATIENTS
16. OC.06.1 THE IMMUNITY-INFLAMMATION-CANCER PATHWAY IN AUTOIMMUNE GASTRITIS: ROLE OF THE OXIDATIVE STRESS
17. P.02.7 MMP3 (METALLOPROTEINASE 3): A NEW MARKER FOR ASSESSING LOSS OF RESPONSE TO INFLIXIMAB IN IBD
18. P.01.20 FREE RADICALS AND OXIDATIVE STRESS-RELATED GENOMIC DAMAGE:WHICH ROLE IN AUTOIMMUNE GASTRITIS?
19. P.09.9: Vascular Endothelial Growth Factor and Hypoxia Inducible Factor: Prognostic Role in HCC Patients Undergoing Conventional and Deb-Mediated Chemoembolization
20. Prognostic role of vascular endothelial growth factor and hypoxia inducible factor in HCC patients after conventional and DEB-mediated chemoembolization
21. Abnormal microvasculature in chronic viral hepatitis
22. PC.01.8 SERUM DETERMINATION OF SQUAMOUS CELLULAR CARCINOMA ANTIGEN AS A BIOMARKER OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL CANCER: A PHASE III STUDY
23. OC.18.6 TNF-A AND IL-10 IN AUTOIMMUNE AND H. PYLORI-RELATED GASTRIC ATROPHY: TISSUE LEVELS IN RELATION TO THE CYTOKINES GENE POLYMORPHISM
24. P.18.12 ANGIOGENESIS FOLLOWING CONVENTIONAL AND DC BEADS-MEDIATED TRANSCATHETER ARTERIAL EMBOLIZATION: ANY DIFFERENCE?
25. F-45 Neoangiogenesis after TACE: any difference between conventional and DC-Beads-mediated transarterial chemoembolization?
26. T-56 Oxidative genomic and mitochondrial damage in relation to telomeric dysfunction in liver carinogenesis
27. P.15.13 ACUTE AND CHRONIC COFFEE EXPOSURE: EFFECTS ON OXIDATIVE DNA DAMAGE AND VIRAL LOAD
28. P.08.22 PROGNOSTIC ROLE OF SCCA-IGM SERUM LEVELS IN HEPATOCELLULAR CARCINOMA (HCC)
29. P.04.2 TELOMERIC DYSFUNCTION AND OXIDATIVE DNA DAMAGE IN PROGRESSION OF VIRAL HEPATITIS TO CIRRHOSIS AND HCC
30. OC.07.3 GENDER SUSCEPTIBILITY DURING ACUTE LIVER INJURY: ANY ROLE FOR THE ANDROGEN RECEPTOR?
31. T-35 SerpinB3 downregulates the proapoptotic p66Shc protein in human hepatoma cells
32. P.1.274: PROTECTIVE EFFECT OF COFFEE ON OXIDATIVE DNA DAMAGE, TELOMERE LENGTH AND APOPTOSIS IN PATIENTS WITH HCV-RELATED CHRONIC HEPATITIS
33. T-13 Protective effect of coffee on oxidative DNA damage in patients with HCV-chronic hepatitis
34. PA.169 WHICH 5-ASA? VARIATION IN COLONIC MUCOSAL CONCENTRATION OF DIFFERENT PHARMACEUTICAL MESALAMINE FORMULATIONS
35. PA.99 PROINFLAMMATORY CYTOKINES AND NF-KB MRNA EXPRESSION IN CHRONIC LIVER DISEASES
36. OC3.06.3 HYPERMETHYLATION OF TPEF AND MINT31 AS AN EARLY EVENT IN GASTRIC CARCINOGENESIS
37. Extrinsic and intrinsic apoptosis pathways in chronic liver diseases
38. Angiogenesis during trans-cathether arterial chemoembolisation (TACE) in hepatocellular carcinoma (HCC)
39. Effect of moderate acute aerobic exercise in patients with Crohn's disease in clinical remission
40. 1 OP Oxidative DNA damage in relation to estrogen receptor status in chronic liver damage and HCC
41. Gastroesophageal junction DNA oxidative damage after H. pylori eradication in HPLC-ED and ELISA
42. Effect of oral zinc supplementation in an animal model of Wilson disease
43. Oxidative DNA damage in ulcerative colitis
44. Reduced plasma antioxidants levels and increased oxidative DNA damage in inflammatory bowel diseases
45. Effects of helicobacter pylori eradication on stomach and oesophageal morphology and biology at short time
46. Helicobacter pylori infection CagA-positive increases the oxidative DNA damage of gastric mucosa
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.